CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Mixed amphetamine salts

Last Updated: December 15, 2004
Result type: Reports
Project Number: SR0027-000
Product Line: Reimbursement Review

Generic Name: Mixed amphetamine salts

Brand Name: Adderall XR

Manufacturer: Shire BioChem Inc.

Therapeutic Area: Attention deficit hyperactivity disorder

Indications: Attention deficit hyperactivity disorder

Submission Type: Resubmission

Project Status: Withdrawn